325 related articles for article (PubMed ID: 25169588)
1. Reverse genetics systems as tools for the development of novel therapies against filoviruses.
Hoenen T; Feldmann H
Expert Rev Anti Infect Ther; 2014 Oct; 12(10):1253-63. PubMed ID: 25169588
[TBL] [Abstract][Full Text] [Related]
2. Minigenomes, transcription and replication competent virus-like particles and beyond: reverse genetics systems for filoviruses and other negative stranded hemorrhagic fever viruses.
Hoenen T; Groseth A; de Kok-Mercado F; Kuhn JH; Wahl-Jensen V
Antiviral Res; 2011 Aug; 91(2):195-208. PubMed ID: 21699921
[TBL] [Abstract][Full Text] [Related]
3. Reverse Genetics Systems for Filoviruses.
Hoenen T; Feldmann H
Methods Mol Biol; 2017; 1602():159-170. PubMed ID: 28508220
[TBL] [Abstract][Full Text] [Related]
4. High-throughput, luciferase-based reverse genetics systems for identifying inhibitors of Marburg and Ebola viruses.
Uebelhoer LS; Albariño CG; McMullan LK; Chakrabarti AK; Vincent JP; Nichol ST; Towner JS
Antiviral Res; 2014 Jun; 106():86-94. PubMed ID: 24713118
[TBL] [Abstract][Full Text] [Related]
5. High-throughput screening for negative-stranded hemorrhagic fever viruses using reverse genetics.
Wendt L; Bostedt L; Hoenen T; Groseth A
Antiviral Res; 2019 Oct; 170():104569. PubMed ID: 31356830
[TBL] [Abstract][Full Text] [Related]
6. Reverse Genetics Systems for Filoviruses.
Bodmer BS; Hoenen T
Methods Mol Biol; 2024; 2733():1-14. PubMed ID: 38064023
[TBL] [Abstract][Full Text] [Related]
7. Filovirus proteins for antiviral drug discovery: Structure/function bases of the replication cycle.
Martin B; Canard B; Decroly E
Antiviral Res; 2017 May; 141():48-61. PubMed ID: 28192094
[TBL] [Abstract][Full Text] [Related]
8. Modeling the Ebolavirus Life Cycle with Transcription and Replication-Competent Viruslike Particle Assays.
Biedenkopf N; Hoenen T
Methods Mol Biol; 2017; 1628():119-131. PubMed ID: 28573615
[TBL] [Abstract][Full Text] [Related]
9. A novel life cycle modeling system for Ebola virus shows a genome length-dependent role of VP24 in virus infectivity.
Watt A; Moukambi F; Banadyga L; Groseth A; Callison J; Herwig A; Ebihara H; Feldmann H; Hoenen T
J Virol; 2014 Sep; 88(18):10511-24. PubMed ID: 24965473
[TBL] [Abstract][Full Text] [Related]
10. Current status of small molecule drug development for Ebola virus and other filoviruses.
Edwards MR; Basler CF
Curr Opin Virol; 2019 Apr; 35():42-56. PubMed ID: 31003196
[TBL] [Abstract][Full Text] [Related]
11. Reverse Genetics of Filoviruses.
Hoenen T; Brandt J; Caì Y; Kuhn JH; Finch C
Curr Top Microbiol Immunol; 2017; 411():421-445. PubMed ID: 28918537
[TBL] [Abstract][Full Text] [Related]
12. Remdesivir inhibits the polymerases of the novel filoviruses Lloviu and Bombali virus.
Bodmer BS; Zierke L; Wendt L; Greßler J; Groseth A; Hoenen T
Antiviral Res; 2021 Aug; 192():105120. PubMed ID: 34126139
[TBL] [Abstract][Full Text] [Related]
13. [Filoviruses].
Takada A
Uirusu; 2012; 62(2):197-208. PubMed ID: 24153230
[TBL] [Abstract][Full Text] [Related]
14. Recombinant Lloviu virus as a tool to study viral replication and host responses.
Hume AJ; Heiden B; Olejnik J; Suder EL; Ross S; Scoon WA; Bullitt E; Ericsson M; White MR; Turcinovic J; Thao TTN; Hekman RM; Kaserman JE; Huang J; Alysandratos KD; Toth GE; Jakab F; Kotton DN; Wilson AA; Emili A; Thiel V; Connor JH; Kemenesi G; Cifuentes D; Mühlberger E
PLoS Pathog; 2022 Feb; 18(2):e1010268. PubMed ID: 35120176
[TBL] [Abstract][Full Text] [Related]
15. Identification of filovirus entry inhibitors targeting the endosomal receptor NPC1 binding site.
Wang LL; Palermo N; Estrada L; Thompson C; Patten JJ; Anantpadma M; Davey RA; Xiang SH
Antiviral Res; 2021 May; 189():105059. PubMed ID: 33705865
[TBL] [Abstract][Full Text] [Related]
16. Minigenome Systems for Filoviruses.
Hoenen T
Methods Mol Biol; 2018; 1604():237-245. PubMed ID: 28986839
[TBL] [Abstract][Full Text] [Related]
17. Generation of Recombinant Ebola Viruses Using Reverse Genetics.
Groseth A
Methods Mol Biol; 2017; 1628():177-188. PubMed ID: 28573619
[TBL] [Abstract][Full Text] [Related]
18. Luciferase-Expressing Ebolaviruses as Tools for Screening of Antivirals.
Hoenen T
Methods Mol Biol; 2017; 1628():189-194. PubMed ID: 28573620
[TBL] [Abstract][Full Text] [Related]
19. An RNA polymerase II-driven Ebola virus minigenome system as an advanced tool for antiviral drug screening.
Nelson EV; Pacheco JR; Hume AJ; Cressey TN; Deflubé LR; Ruedas JB; Connor JH; Ebihara H; Mühlberger E
Antiviral Res; 2017 Oct; 146():21-27. PubMed ID: 28807685
[TBL] [Abstract][Full Text] [Related]
20. Filoviruses: Ecology, Molecular Biology, and Evolution.
Emanuel J; Marzi A; Feldmann H
Adv Virus Res; 2018; 100():189-221. PubMed ID: 29551136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
